Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers

Prostate cancer is the most diagnosed cancer among men in the United States. While the majority of patients who undergo surgery (prostatectomy) will essentially be cured, about 30–40% men remain at risk for disease progression and recurrence. Currently, patients are deemed at risk by evaluation of c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vergara, Ismael A., Erho, Nicholas, Triche, Timothy J., Ghadessi, Mercedeh, Crisan, Anamaria, Sierocinski, Thomas, Black, Peter C., Buerki, Christine, Davicioni, Elai
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Research Foundation 2012
Assuntos:
Genetics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3284255/
https://ncbi.nlm.nih.gov/pubmed/22371711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2012.00023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados